Recurrent Rectal Cancer: Clinical Trials

7 trials for Recurrent Rectal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 recruiting, 1 unknown. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Terminated 2, Recruiting 1, Unknown 1
Phase 21Unknown 1

Follow Recurrent Rectal Cancer: new trials by email Literature Review of Recurrent Rectal Cancer trials Research Report on Recurrent Rectal Cancer

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Induction Chemotherapy for Locally Recurrent Rectal Cancer
Combination drug, Chemoradiotherapy, Surgery locally recurrent rectal cancer - Recurrent Rectal Cancer
Phase 3RecruitingCatharina Ziekenhuis Eindhoven3642020-11-132022-09-06
SGM-101 in Locally Advanced and Recurrent Rectal Cancer
SGM-101 - Rectal Cancer, Recurrent Rectal Cancer
Phase 2 / Phase 3UnknownLeiden University Medical Center2032019-10-222020-11-24
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
irinotecan hydrochloride, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 3TerminatedNational Cancer Institute (NCI)722007-06-012014-07-31
Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
oxaliplatin, leucovorin calcium, capecitabine - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Phase 3TerminatedNational Cancer Institute (NCI)22002004-04-012013-01-25
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated
bevacizumab, oxaliplatin, leucovorin calcium - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Phase 3CompletedNational Cancer Institute (NCI)8802001-09-012013-01-24
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
irinotecan hydrochloride, oxaliplatin, leucovorin calcium - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum
Phase 3CompletedNational Cancer Institute (NCI)5601999-11-012013-05-03
Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
fluorouracil, eniluracil - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Phase 3CompletedNational Cancer Institute (NCI)9501999-04-012013-01-24

Narrower conditions

Rectal Neoplasms (7)  ·  Colonic Neoplasms (5)  ·  Margins of Excision (1)

Broader conditions

Colorectal Neoplasms (7)  ·  Digestive System Diseases (7)  ·  Digestive System Neoplasms (7)  ·  Gastrointestinal Diseases (7)  ·  Gastrointestinal Neoplasms (7)  ·  Intestinal Diseases (7)  ·  Intestinal Neoplasms (7)  ·  Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Rectal Diseases (7)  ·  Colonic Diseases (5)  ·  Morphological and Microscopic Findings (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Fluorouracil (5)  ·  Leucovorin (4)  ·  Bevacizumab (3)  ·  Oxaliplatin (3)  ·  Irinotecan (2)  ·  Capecitabine (1)  ·  Cetuximab (1)  ·  Chemoradiotherapy (1)  ·  Drug Combinations (1)  ·  Folfox protocol (1)  ·  IFL protocol (1)  ·  eniluracil (1)

Sponsors

National Cancer Institute (NCI) (5)  ·  Catharina Ziekenhuis Eindhoven (1)  ·  Leiden University Medical Center (1)

Countries

United States (5)  ·  Netherlands (2)  ·  Belgium (1)  ·  Norway (1)  ·  Portugal (1)  ·  Sweden (1)

Top investigators

Bruce Giantonio (1)  ·  Charles Blanke (1)  ·  Henry Pitot (1)  ·  John Hines (1)  ·  Philip Gold (1)  ·  Pim Burger, MD (1)

NIH funding

U10CA021115 (2), U10CA032102 (2), U10CA025224 (1)